Myriad Genetics reported $389.4M in Current Assets for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Accelerate Diagnostics AXDX:US 81.81M 176K
Agilent A:US $ 3514M 31M
Becton, Dickinson and BDX:US $ 10000M 463M
Bio Rad Laboratories BIO:US $ 2175.32M 35.48M
Biocept BIOC:US $ 35.3M 2.7M
Bruker BRKR:US $ 1946.2M 21.2M
Danaher DHR:US $ 15392M 1380M
Exact Sciences EXAS:US $ 1775.3M 423.29M
Fluidigm FLDM:US $ 96.33M 21.34M
Genmark Diagnostics GNMK:US $ 172.96M 2.95M
Hologic HOLX:US $ 2662.4M 66.1M
Illumina ILMN:US $ 5642M 1159M
Luminex LMNX:US $ 481.78M 27.25M
Mettler Toledo International MTD:US 1.08B 23.3M
Myriad Genetics MYGN:US $ 389.4M 5.1M
Nanostring Technologies NSTG:US $ 474.44M 24.54M
Orasure Technologies OSUR:US $ 292.41M 3.52M
Oxford Immunotec Global OXFD:US $ 188.37M 1.42M
Pacific Biosciences Of California PACB:US $ 1195.12M 839.53M
Perkinelmer PKI:US $ 2674.57M 435.65M
Quest Diagnostics DGX:US $ 2146M 853M
Thermo Fisher Scientific TMO:US $ 17685M 4272M
Veracyte VCYT:US $ 362.09M 13.59M
Waters WAT:US $ 1688.41M 287.38M